Comparison
Modafinil vs Theobromine
Modafinil
A eugeroic — a wakefulness-promoting compound — originally developed for narcolepsy. The most-studied prescription cognitive enhancer outside of ADHD treatment. Produces 12–15 hour windows of sustained alertness without the euphoria, abuse potential, or cardiovascular load of amphetamines. Prescription-only in nearly every jurisdiction.
Theobromine
Methylxanthine from cocoa. Mild stimulant effect, slower and longer than caffeine. Lower anxiety and cardiovascular load.
| Field | Modafinil | Theobromine |
|---|---|---|
| Category | stimulant | stimulant |
| Dose range | 100–200mg | 200–600mg |
| Half-life | 14h | — |
| Onset | 45min | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●○○ | ●●●●● |
| Legal (US) | USSchedule IV | USOTC |
| PubMed refs | 3200 | 800 |
The comparison in plain English
Auto-generated from dataModafinil and Theobromine are both in the stimulant category respectively. Modafinil A eugeroic — a wakefulness-promoting compound — originally developed for narcolepsy. Theobromine Methylxanthine from cocoa.
Bottom line
Modafinil (evidence A, safety 3/5) has a weaker evidence base than Theobromine (evidence B, safety 5/5). Theobromine has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Modafinil if
Modafinil is the better fit when your goal aligns with its mechanism (Inhibits dopamine reuptake via the dopamine transporter (DAT), increasing extracellular dopamine in the prefrontal cortex) and the dose range (100–200mg) suits your protocol. Half-life is 14h.
Choose Theobromine if
Theobromine is the better fit when your goal aligns with its mechanism (Adenosine receptor antagonist similar to caffeine but with much lower potency and longer half-life (~7-12 hours)) and the dose range (200–600mg) suits your protocol. Half-life is —h.